Global Hydrophobic Interaction Chromatography Market Size study & Forecast, by Product and Service (Resins, Columns, Services, Others) by Sample Type (Monoclonal Antibodies, Vaccines, Others) by End-User (Research & Academic Institutes) and Regional Forec

The Global Hydrophobic Interaction Chromatography (HIC) Market, valued at nearly USD 0.24 billion in 2024, is projected to expand at a notable CAGR of 7.70% between 2025 and 2035, ultimately reaching approximately USD 0.54 billion. Hydrophobic interaction chromatography, a pivotal separation technique in bioprocessing, leverages hydrophobic interactions between proteins and specialized resins to achieve high-purity separations without denaturing sensitive biomolecules. As the pharmaceutical and biotechnology sectors accelerate the production of complex biologics—ranging from monoclonal antibodies to next-generation vaccines—the adoption of HIC has emerged as a cornerstone in downstream purification workflows. Its capacity to maintain protein functionality while delivering high yield has positioned it as an indispensable method in the manufacturing of advanced therapeutics. The surge in biologics demand, coupled with intensifying regulatory requirements for purity and process validation, is propelling the global HIC market forward.

Expanding R&D expenditure in life sciences, alongside the explosive growth of the biopharmaceutical pipeline, has significantly bolstered the market's momentum. An increasing number of blockbuster biologics are nearing patent expiry, triggering a wave of biosimilar development that heavily depends on robust and cost-effective purification processes such as HIC. Technological advancements—such as the development of high-capacity resins, automation-enabled chromatography systems, and integration with multi-modal purification strategies—are reshaping operational efficiencies for research institutions and manufacturers alike. Additionally, the widespread focus on vaccine production in the wake of global health emergencies has spotlighted HIC’s role in ensuring product safety and consistency, further anchoring its demand. However, the high cost of resins and consumables, coupled with the technical complexity of optimization, may present short-term adoption barriers, particularly for smaller research facilities.

North America currently leads the global hydrophobic interaction chromatography market, buoyed by its extensive biopharmaceutical manufacturing infrastructure, strong academic research base, and sustained government funding for life sciences innovation. The United States, home to a significant number of contract development and manufacturing organizations (CDMOs) and biotech startups, serves as the market’s epicenter. Europe follows closely, supported by robust regulatory frameworks, thriving biosimilar pipelines, and well-established biotech hubs in Germany, Switzerland, and the UK. Meanwhile, the Asia Pacific region is forecast to register the fastest growth rate, driven by escalating biopharma investments in China, India, and South Korea, increasing adoption of advanced purification technologies, and rising collaborations between local players and global pharmaceutical giants. Latin America and the Middle East & Africa are steadily emerging, with gradual improvements in research infrastructure and expanding clinical trial activities.

Major market players included in this report are:
• GE Healthcare
• Sartorius AG
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Tosoh Corporation
• Danaher Corporation
• Agilent Technologies, Inc.
• Waters Corporation
• Mitsubishi Chemical Corporation
• PerkinElmer Inc.
• Novasep Holding SAS
• Shimadzu Corporation
• Repligen Corporation
• Purolite Corporation

Global Hydrophobic Interaction Chromatography Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product and Service:
• Resins
• Columns
• Services
• Others

By Sample Type:
• Monoclonal Antibodies
• Vaccines
• Others

By End-User:
• Research & Academic Institutes

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more